Andrew C Lake Selected Research

Heparin (Liquaemin)

12/2006	Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
3/2004	The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew C Lake Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 03/2004
1	Ischemia 12/2006
1	Carcinogenesis 03/2004
1	Leiomyoma (Uterine Fibroids) 03/2004
1	Vascular Diseases (Vascular Disease) 11/2003
1	Wilms Tumor (Wilm's Tumor) 01/2003

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
2	Heparin (Liquaemin)FDA LinkGeneric 12/2006 - 03/2004
1	CytokinesIBA 01/2020
1	Chemokine CCL3IBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	fucoidanIBA 12/2006
1	Biological ProductsIBA 12/2006
1	Polysaccharides (Glycans)IBA 12/2006
1	Messenger RNA (mRNA)IBA 03/2004
1	Cysteine (L-Cysteine)FDA Link 01/2003
1	Connective Tissue Growth FactorIBA 01/2003

Therapy/Procedure

1	Therapeutics 11/2003